Overview

A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients

Status:
Not yet recruiting

Trial end date:
2022-09-20

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess and compare the effectiveness and safety of high-dose dual therapy and half-dose clarithromycin-containing bismuth quadruple therapy in elderly patients for eradicating H.pylori.

Phase:

Phase 4

Details

Lead Sponsor:

Shandong University

Treatments:

Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Clarithromycin
Dexlansoprazole
Lansoprazole